ed., Bone-Certain Aspects ofNeoplasia, 1973). Like the original RFB osteoma virus stock, viruses derived from the molecular RFB clones induced multiple osteomas in mice of the CBA/Ca strain. The cloned RFB viruses were indistinguishable by restriction enzyme analysis and by nucleotide sequence analysis of their long-terminal-repeat regions and showed close relatedness to the Akv murine leukemia virus.
A number of molecularly cloned ecotropic, N-tropic murine leukemia viruses (MLVs) induce osteomas (benign bone tumors) and osteopetrosis together with malignant lymphomas when the viruses are injected into newborn NMRI mice (12, 15, 16, 20) . The virus-induced bone lesions are characterized by localized increased bone formation in the affected animals (15, 16 ).
Finkel and coworkers described a virus stock, termed RFB osteoma virus, originating from an extract prepared from three tumors of a CF1 mouse: an FBJ-virus-induced osteosarcoma, a lymphosarcoma, and an osteoma (6) . This noncloned RFB virus, which had been passaged as cell-free osteoma extract in CF1 mice, induced exclusively osteomas 2 to 3 months after injection in the majority of inoculated CF1 mice (5, 6, 27) . The RFB osteoma virus stock does not transform cells in culture (27) and may therefore consist of replication-competent MLVs with distinct pathogenic effects on cells of the mouse skeleton. As the viruses of the RFB osteoma virus stock are the most potent bone-pathogenic nonacute MLVs hitherto described, a well-characterized cloned isolate with the properties of this virus stock would be an optimal candidate for investigating the mechanisms of retrovirus-induced deregulation of bone formation.
The RFB osteoma virus stock, VR-909, was obtained from the American Type Culture Collection (Rockville, Md.). NIH 3T3 cells, which harbor no endogenous ecotropic provirus (2), were productively infected with the virus stock, resulting in a cell line named NIH/VR-909. The NIH/VR-909 cells produced N-tropic (9, 18) and XC-positive (21) viruses (data not shown). The pathogenicities of the NIH/VR-909-derived viruses were investigated by injection of cell-free supernatant (a 0.22-,um-particle-diameter filtrate) into newborn mice of the CBA/Ca strain ( Table 1) . The CBA/Ca mouse strain (14) was chosen because it lacks endogenous ecotropic proviruses (2) . It is characterized by a very low incidence of spontaneous bone lesions and lymphoma (5, 13) . Furthermore, the RFB osteoma virus stock has been * Corresponding author.
reported to be highly oncogenic in this mouse strain (27) . The NIH/VR-909-derived viruses induced an average of 9.6 osteomas per mouse in all injected CBA/Ca mice (Table 1) . One case of malignant lymphoma was observed (Table 1) . This disease pattern is very similar to that reported for the original RFB osteoma virus stock in CBA, CF1, and NIH Swiss mice, in which only osteoma induction was reported (6, 27) . Like the original RFB virus stock (6), the NIH/VR-909-derived viruses induced multiple osteomas (Table 1) . The time of onset of osteoma formation in the CBA/Ca mice is unknown, because the osteoma development was not followed by regular X-ray analysis of the mice as was done in the original studies on CF1 mice (6) . In our experiments, CBA/Ca mice were killed when osteomas were macroscopically apparent after about 13 months; at this stage, the mice did not show overt signs of illness.
For RNase T, fingerprint analysis, viral 70S RNAs were harvested from NIH/VR-909 cells and subjected to RNase T, digestion, radioactive labeling, and two-dimensional gel electrophoresis as described elsewhere (19) . The resulting fingerprint consisted of RNase Tl-resistant oligonucleotides in equimolar amounts (data not shown), indicating the presence of only one major viral component in the supernatant of the NIH/VR-909 cells. The fingerprint was closely related to that of the prototype ecotropic MLV, Akv MLV (Fig. 1A) .
NIH/VR-909 cells were cloned by endpoint dilution. Single-cell clones were tested for virus production by infectious center assay (18) Long terminal repeat (LTR) regions of very similar structure may exhibit significant differences in biological properties (8, 25) . In order to further characterize and compare the two independent molecular clones from the REB osteoma virus stock, the LTR regions of both clones were subcloned in the plasmid vector pUC9 and sequenced by the dideoxy method with the use of synthetic oligonucleotides (26) . The nucleotide sequences of the LTR regions of the independent molecular clones, RFB-14 and RFB-18, were found to be identical (Fig. 2) . The sequence is related to that of the prototype ecotropic MLV, Akv MLV (4, 10) . It differs from the LTR sequence of Akv by its tandem repeat organization in U3 and by four point differences located in U3 within and outside the repeat region (listed in the legend to Fig. 2A Akv has a perfect 99-bp tandem repeat (Fig. 2B) . and RFB-18 both have perfect 64-bp tandem repeats. Furthermore, a 28-bp sequence representing the 3' part of the 64-bp repeat is also localized 5' to the 64-bp tandem repeats and is thereby present in three copies (Fig. 2) . T'he pathogenicities of RFB-14-and RFB-18-derived viruses were investigated in newborn CBA/Ca mice by injection of cell-free supernatant (a 0.22-p.m-particle-diameter ifiltrate) from NIH 3T3 cells productively transfected with RFB-14 and RFB-18 DNAs (Table 1, Fig. 3 ). The viruses showed the same pathogenic effect in CBAICa mice as NIHIVR-909-and NIHIRFB-K7-derived viruses, with similar incidences and average latency periods ( Fig. 3 injected with the NIH/VR-909-and RFB/NIH-K7-derived viruses (Table 1) but was very close to the average number of 5 osteomas per mouse induced by the original RFB osteoma virus stock in mice of the CF1 strain (6). A very low incidence of malignant lymphomas was observed in all groups of mice injected with NIH/VR-909-, RFB/NIH-K7-, RFB-14-, or RFB-18-derived viruses (Table 1) .
In summary, we have molecularly cloned two replicationcompetent MLVs from the RFB osteoma virus stock. Both encode N-tropic, XC-positive viruses and they cannot be distinguished from each other by restriction enzyme analysis and partial nucleotide sequence analysis. Both clones encode viruses that induce a pattern of disease indistinguishable from that induced by NIH/VR-909-derived viruses. Therefore, RFB-14 and RFB-18 represent the major pathogenic entity of the NIH/VR-909-derived viruses. These viruses represent the most bone-pathogenic molecularly cloned replication-competent MLVs yet described. The high degree of similarity in pathogenicity patterns between the cloned RFB viruses and that reported for the original RFB osteoma virus stock by Finkel and coworkers (6) indicates that the cloned RFB viruses represent a major pathogenic potential of the original RFB osteoma virus stock.
The prototype ecotropic MLV, Akv MLV, has also been injected into newborn mice of the CBA/Ca strain and was found to induce osteomas and malignant lymphomas in 75% of the animals (15, 24) . In contrast, lymphoma induction by the cloned RFB viruses was very low in CBA/Ca mice. With respect to osteoma induction, the RFB-14-and RFB-18-derived viruses were more pathogenic in CBA/Ca mice than was the Akv MLV. Moreover, on average, more osteomas were induced per mouse by the cloned RFB viruses than by Akv MLV (15) and RFB-induced osteomas appeared approximately 3 month earlier than those induced by Akv MLV (24) .
The molecular mechanism of MLV-induced new bone formation is yet unresolved. Results obtained with the molecularly cloned OA MLV, which also induces osteomas, though at a lower incidence (12) , indicate that the target cells for bone-pathogenic MLVs in the skeleton are progenitor cells of the osteoblastic lineage (17, 22 resulted in an enhanced expression of alkaline phosphatase, a marker of osteogenic differentiation (22) . These data suggest that retroviruses directly affect osteoblast progenitor cells as primary target cells in the skeleton, resulting in the continuous formation of new bone. The availability of the molecular RFB clones provides the basis for detailed analysis of the mechanisms underlying the effects of retroviruses on the skeleton.
Nucleotide sequence accession number. The EMBL Data Library accession number for the RFB LTR sequence in Fig. 
